Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Fähndrich

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Innere Medizin (Heidelberg, Germany)|May 24, 2024
[Alpha 1-antitrypsin deficiency]Sebastian Fähndrich, Robert Bals
Deutsche Medizinische Wochenschrift (1946)|October 5, 2016
[Alpha-1-antitrypsin deficiency - an update]Nikolas Bernhard, Robert Bals, Sebastian Fähndrich
Lung Cancer (Amsterdam, Netherlands)|June 8, 2006
Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: a phase I studyGunther Klautke, Sebastian Fähndrich, Sabine Semrau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2020
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatmentRick Dersch, Thomas Wehrum, Sebastian Fähndrich, et al.
Respiratory Medicine|July 23, 2017
Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV<sub>1</sub> in individuals with PiZZ alpha-1-antitrypsin deficiencySebastian Fähndrich, Nikolas Bernhard, Philipp M Lepper, et al.
Respiratory Medicine|December 6, 2017
Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZNikolas Bernhard, Philipp M Lepper, Claus Vogelmeier, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 30, 2017
Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German RegistryNikolas Bernhard, Philipp M Lepper, Claus Vogelmeier, et al.
COPD|May 5, 2015
Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registrySebastian Fähndrich, Christian Herr, Timm Greulich, et al.
Therapeutic Advances in Respiratory Disease|January 7, 2026
Advances in orphan drug development for alpha-1 antitrypsin deficiency: a 2025 update from the FDA and EMAPhilipp Höger, Markus Ries, Arturo Olivares Rivera, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 13, 2017
Extracorporeal membrane oxygenation (ECMO) as salvage treatment for pulmonary Echinococcus granulosus infection with acute cyst ruptureSören L Becker, Sebastian Fähndrich, Franziska C Trudzinski, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Innere Medizin (Heidelberg, Germany)|May 24, 2024
[Alpha 1-antitrypsin deficiency]Sebastian Fähndrich, Robert Bals
Deutsche Medizinische Wochenschrift (1946)|October 5, 2016
[Alpha-1-antitrypsin deficiency - an update]Nikolas Bernhard, Robert Bals, Sebastian Fähndrich
Lung Cancer (Amsterdam, Netherlands)|June 8, 2006
Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: a phase I studyGunther Klautke, Sebastian Fähndrich, Sabine Semrau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2020
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatmentRick Dersch, Thomas Wehrum, Sebastian Fähndrich, et al.
Respiratory Medicine|July 23, 2017
Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV<sub>1</sub> in individuals with PiZZ alpha-1-antitrypsin deficiencySebastian Fähndrich, Nikolas Bernhard, Philipp M Lepper, et al.
Respiratory Medicine|December 6, 2017
Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZNikolas Bernhard, Philipp M Lepper, Claus Vogelmeier, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 30, 2017
Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German RegistryNikolas Bernhard, Philipp M Lepper, Claus Vogelmeier, et al.
COPD|May 5, 2015
Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registrySebastian Fähndrich, Christian Herr, Timm Greulich, et al.
Therapeutic Advances in Respiratory Disease|January 7, 2026
Advances in orphan drug development for alpha-1 antitrypsin deficiency: a 2025 update from the FDA and EMAPhilipp Höger, Markus Ries, Arturo Olivares Rivera, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 13, 2017
Extracorporeal membrane oxygenation (ECMO) as salvage treatment for pulmonary Echinococcus granulosus infection with acute cyst ruptureSören L Becker, Sebastian Fähndrich, Franziska C Trudzinski, et al.
Pageof 4